3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
CNS
1
Conditions
Lymphoma
2
Leukemia, Myeloid, Chronic-Phase
2
Leukemia, Myeloid, Acute
2
Leukemia
2
Hodgkin Disease
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Neoplasms, Plasma Cell
1
Myelodysplastic Syndromes
1
Multiple Myeloma
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large-Cell, Immunoblastic
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
1
Leukemia, Myeloid, Accelerated Phase
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Gliosarcoma
1
Glioma
1
Glioblastoma
1
Burkitt Lymphoma
1
Blast Crisis
1
Interventions
Temozolomide
109
Magnetic Resonance Spectroscopy
52
Bevacizumab
52
Radiotherapy
44
Irinotecan
27
Blood Specimen Collection
19
Surgical Procedures, Operative
16
Radiation
15
Aminolevulinic Acid
15
Carboplatin
13
fluorodopa F 18
12
Nivolumab
12
Radiotherapy, Intensity-Modulated
11
Carmustine
11
Radiosurgery
10
Magnetic Resonance Imaging
10
pembrolizumab
9
Topotecan
9
Specimen Handling
9
Everolimus
9
Erlotinib Hydrochloride
9
Biopsy
9
poly ICLC
8
Surveys and Questionnaires
8
Standard of Care
8
Etoposide
8
Drug Therapy
8
Lomustine
7
Filgrastim
7
Cyclophosphamide
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Glioma
×
Daclizumab
×
Clear all
NCT00626015
2016-01-21
ZAP IT
Duke University
Phase 1
Completed
16 enrolled